These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 34697179)

  • 1. Comparison of Three Assays for Total and Free PSA Using Hybritech and WHO Calibrations.
    Garrido MM; Marta JC; Ribeiro RM; Pinheiro LC; Holdenrieder S; Guimarães JT
    In Vivo; 2021; 35(6):3431-3439. PubMed ID: 34697179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toward metrological traceability in the determination of prostate-specific antigen (PSA): calibrating Beckman Coulter Hybritech Access PSA assays to WHO standards compared with the traditional Hybritech standards.
    Stephan C; Kahrs AM; Klotzek S; Reiche J; Müller C; Lein M; Deger S; Miller K; Jung K
    Clin Chem Lab Med; 2008; 46(5):623-9. PubMed ID: 18839463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Standardization of PSA measures: a reappraisal and an experience with WHO calibration of Beckman Coulter Access Hybritech total and free PSA.
    Vignati G; Giovanelli L
    Int J Biol Markers; 2007; 22(4):295-301. PubMed ID: 18161661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Consistency and diagnostic accuracy of 4 assays in the detection of the total and free prostate-specific antigen.
    Deng L; Yue D; Wang X; Li H
    Transl Androl Urol; 2023 Feb; 12(2):261-270. PubMed ID: 36915871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prostate health index and the percentage of [-2]proPSA maintain their diagnostic performance when calculated with total and free PSA from different manufacturers.
    Garrido MM; Ribeiro R; Pinheiro LC; Holdenrieder S; Guimarães JT
    Clin Chem Lab Med; 2021 Oct; 59(11):1869-1877. PubMed ID: 34318651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate cancer screening: clinical impact of WHO calibration of Beckman Coulter Access prostate-specific antigen assays.
    Fillée C; Tombal B; Philippe M
    Clin Chem Lab Med; 2010 Feb; 48(2):285-8. PubMed ID: 20001849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interchangeability of measurements of total and free prostate-specific antigen in serum with 5 frequently used assay combinations: an update.
    Stephan C; Klaas M; Müller C; Schnorr D; Loening SA; Jung K
    Clin Chem; 2006 Jan; 52(1):59-64. PubMed ID: 16391327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intermethod differences in results for total PSA, free PSA, and percentage of free PSA.
    Slev PR; La'ulu SL; Roberts WL
    Am J Clin Pathol; 2008 Jun; 129(6):952-8. PubMed ID: 18480013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discordant prostate specific antigen test results despite WHO assay standardization.
    Boegemann M; Arsov C; Hadaschik B; Herkommer K; Imkamp F; Nofer JR; Gerß J; Albers P; Semjonow A
    Int J Biol Markers; 2018 Aug; 33(3):275-282. PubMed ID: 29734838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of 6 automated assays for total and free prostate-specific antigen with special reference to their reactivity toward the WHO 96/670 reference preparation.
    Kort SA; Martens F; Vanpoucke H; van Duijnhoven HL; Blankenstein MA
    Clin Chem; 2006 Aug; 52(8):1568-74. PubMed ID: 16762996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 20-25% lower concentrations of total and free prostate-specific antigen (PSA) after calibration of PSA assays to the WHO reference materials--analysis of 1098 patients in four centers.
    Stephan C; Bangma C; Vignati G; Bartsch G; Lein M; Jung K; Philippe M; Semjonow A; Catalona WJ
    Int J Biol Markers; 2009; 24(2):65-9. PubMed ID: 19634108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of free-to-total prostate specific antigen variability on the early diagnosis of prostate cancer: a comparative study of three immunoassays.
    de la Taille A; Houlgatte A; Houdelette P; Goluboff ET; Berlizot P; Ricordel I
    Br J Urol; 1998 Sep; 82(3):389-92. PubMed ID: 9772876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discordant total and free prostate-specific antigen (PSA) assays: does calibration with WHO reference materials diminish the problem?
    Stephan C; Köpke T; Semjonow A; Lein M; Deger S; Schrader M; Miller K; Jung K
    Clin Chem Lab Med; 2009; 47(11):1325-31. PubMed ID: 19778292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical impact of new prostate-specific antigen WHO standardization on biopsy rates and cancer detection.
    Jansen FH; Roobol M; Bangma CH; van Schaik RH
    Clin Chem; 2008 Dec; 54(12):1999-2006. PubMed ID: 18927249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Managing the impact of inter-method bias of prostate specific antigen assays on biopsy referral: the key to move towards precision health in prostate cancer management.
    Ferraro S; Biganzoli G; Bussetti M; Castaldi S; Biganzoli EM; Plebani M
    Clin Chem Lab Med; 2023 Jan; 61(1):142-153. PubMed ID: 36322977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variability of assay methods for total and free PSA after WHO standardization.
    Foj L; Filella X; Alcover J; Augé JM; Escudero JM; Molina R
    Tumour Biol; 2014 Mar; 35(3):1867-73. PubMed ID: 24092573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interassay Variability and Clinical Implications of Five Different Prostate-specific Antigen Assays.
    Kaufmann B; Pellegrino P; Zuluaga L; Ben-David R; Müntener M; Keller EX; Spanaus K; von Eckardstein A; Gorin MA; Poyet C
    Eur Urol Open Sci; 2024 May; 63():4-12. PubMed ID: 38558765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different prostate-specific antigen assays give different results on the same blood sample: an obstacle to recommending uniform limits for prostate biopsies.
    Stephan C; Kramer J; Meyer HA; Kristiansen G; Ziemer S; Deger S; Lein M; Loening SA; Jung K
    BJU Int; 2007 Jun; 99(6):1427-31. PubMed ID: 17355366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Standardization of assay methods reduces variability of total PSA measurements: an Irish study.
    Forde JC; Marignol L; Blake O; McDermott T; Grainger R; Crowley VE; Lynch TH
    BJU Int; 2012 Sep; 110(5):644-50. PubMed ID: 22897326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An artificial neural network for five different assay systems of prostate-specific antigen in prostate cancer diagnostics.
    Stephan C; Cammann H; Meyer HA; Müller C; Deger S; Lein M; Jung K
    BJU Int; 2008 Sep; 102(7):799-805. PubMed ID: 18522632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.